Strategic Financial Services’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
CIS
MWM
GAM
Strategic Financial Services's SBIO Position: Q2 2026 in Review
Strategic Financial Services sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2026, closing a stake of 24,869 shares — an estimated $1.3M sold.
Strategic Financial Services first reported a position in SBIO in Q4 2021 and held it in 18 quarters. The position peaked at $1.75M in Q3 2023. 66 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.
- Strategic Financial Services reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2026 after selling out during the quarter.
- Strategic Financial Services sold 24,869 ALPS Medical Breakthroughs ETF shares in Q2 2026, an estimated $1.3M.
- Strategic Financial Services first reported a position in ALPS Medical Breakthroughs ETF in Q4 2021 and held it in 18 quarters.
- Strategic Financial Services's ALPS Medical Breakthroughs ETF position peaked at $1.75M in Q3 2023.
- 66 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.
Based on Strategic Financial Services's 13F filing for Q2 2026, filed 24 Aug 2026.